医院管理

基于压疮治疗方式的不同对 DRG 入组的特征与应用的研究

A study on the characteristics and application of DRG admission based on different treatment methods for pressure ulcers

:1599-1604
 
       目的   通过对压疮不同治疗方式的分析,探讨疾病诊断相关分组(DRG)组合的特征,提高核心疾病诊断相关组(ADRG)的入组率和提升相对权重值,从而提升医疗服务效率和水平。方法   使用医院DRGs分析评价系统以及EXCEL软件筛选出2023—2024年广州市第一人民医院主要诊断压疮疾病病例,分析ADRG组合的特征。结果   根据压疮疾病不同治疗方式,主要诊断为压疮(L89)的176病例进入相对的外科治疗组和内科治疗组,ADRG组分别为JD1组合、JJ1组合、JV1组合。JJ1组合治疗方案以创面封闭式负压引流为主;JD1组合的外科治疗方式均是以皮肤和皮下坏死组织的切除清创术+创面封闭式负压引流术(VSD)的手术治疗方案。JD13组、JD15组比JJ13组、JJ15组,相对权重分别高2.35和1.48。26例患者的住院时间均超过60 d,导致进入了QY组合。结论   利用好DRGs工具能有效地提高压疮的入组率,结合精细化的首页质量管理,提升DRGs的组合权重值及医疗服务效率和水平。
       Objective  To analyze  different treatment methods for  pressure  ulcers and explore the characteristics of Diagnosis-Related Groups(DRGs)to improve the admission rate of Adjacent DRGs(ADRGs)and enhance the  relative weight value,thereby improving the efficiency and level of medical services.Methods  Using the DRGs management system and EXCEL software,cases of pressure ulcer disease from Class A tertiary hospital in Guangzhou from 2023 to 2024 were selected,with pressure ulcers as the primary diagnosis,and analyzed the characteristics of ADRG combinations.Results  Based on different treatment methods for pressure ulcers,176 cases primarily diagnosed with pressure ulcers(L89)were categorized into  relative surgical and medical treatment groups,with ADRG groups being JD1,JJ1,and JV1 combinations.The JJ1 group’s treatment plan primarily focused on closed wound negative pressure drainage,the surgical treatment method for JD1 group involved skin and subcutaneous necrotic tissue excision and debridement surgery combined with closed wound negative pressure drainage(VSD).The  relative weights of JD13 and JD15 groups were 2.35 and 1.48,higher than those of JJ13 and JJ15 groups.Twenty-six cases had an average hospital stay exceeding 60 days,leading to their categorization into the QY group.Conclusions  Utilizing the DRG tool effectively improves the admission rate for pressure ulcer diseases.By combining it with refined quality management on the first page of medical records,the combination weight value of DRGs and the efficiency and level of medical services can be enhanced.
医院管理

广州某三甲医院脑梗死住院费用及其影响因素分析

Analysis of hospitalization expenses and influencing factors of cerebral infarction in a tertiary general hospital in Guangzhou

:950-957
 
目的 分析广州某三甲医院脑梗死患者住院费用的变化以及影响因素,为有效减轻患者疾病经济负担提供参考依据。方法 提取广州某三甲医院2015—2022年出院诊断ICD-10前三位编码为I63的病案首页数据,并采用IBM SPSS 20.0软件对费用结构进行描述性统计分析,以多重线性回归分析患者住院费用的影响因素。结果 2015—2022年脑梗死患者的平均住院费用年均增长率为2.86%;费用结构以药品费为主,占比逐年下降,至2022年占比为27.74%,技术劳务性费用占比逐年增加,至2022年占比为47.41%;住院费用主要受医院感染情况、住院天数以及支付方式等因素影响(F=990.10,P<0.001)。结论 脑梗死患者的住院费用结构显著优化,但患者的疾病经济负担仍然较重,且费用受多种因素的综合影响。建议通过提高医疗质量与服务效能,并严格落实临床路径管理,减少不必要的检查以及耗材使用,以期最大程度地减轻患者的负担。
Objective To analyze the structural changes and influencing factors of the hospitalization expenses for patients with cerebral infarction in a tertiary general hospital in Guangzhou,and provide a scientific basis for reducing economic burden of the patients.Methods The front page data of medical records with the main diagnosis of I63 were collected in the sample hospital.Descriptive statistics analysis of hospitalization expenses structure and multiple linear regression analysis of the influencing factors were carried out by SPSS 20.0.Results The annual growth rate of average hospitalization expenses of cerebral infarction patients from 2015 to 2022 in the sample hospital was 2.86% per year.The highest proportion of hospitalization expenses was medicine fee,the proportion of which declined year by year with a minimum 27.74% in 2022.The proportion of technical labor costs accelerated year by year with a maximum 47.41% in 2022.This study revealed the main factors influencing hospitalization expenses were hospital internal infection or not,length of stay,payment method and so on(F=990.10,P<0.001).Conclusions The structure of hospitalization expenses for cerebral infarction patients was significantly optimized,but the economic burden of patients was still heavy affected by a combination of factors.In order to minimize the burden of patients,hospitals should improve medical quality and service efficiency and implement clinical pathway management strictly,to reduce unnecessary inspections and consumables.
论著

基于DRG分析临床路径管理对住院费用的影响

DRG-based analysis of the impacts on inpatient costs incurred clinical pathway management

:74-77
 
目的 运用DRG分析临床路径管理对患者住院费用的影响。方法 采用BJ-DRGs分组器,选取2016年广州某三级综合医院的出院患者病案首页信息及DRG分组信息,对比是否实施临床路径管理对患者的总体住院费用影响及各DRG组的住院费用差异。结果 路径组中位住院费用为9 239.41元,低于对照组的12 358.06元,差异有统计学意义(P<0.001)。费用构成分析发现,路径组的治疗费、检查费、药品费、手术费和其他费低于对照组,而材料费用相对较高。比较的14个DRG组中,6个DRG组的路径组住院费用低于对照组。结论 实行临床路径管理可降低患者住院费用、改变费用构成。结合DRG积极推进临床路径精细化管理,可有效控制病种成本,遏制医疗费用的不合理增长。
Objective Using DRG to analyze the impacts on inpatient costs of a hospital in Guangzhou as incurred by clinical pathway management. Methods As performed by BJ-DRGs, we selected DRG grouping information and medical record homepage information of the inpatients discharged from a tertiary hospital in Guangzhou in 2016. Then we compared the impacts of clinical pathway management on overall inpatients costs and the difference of inpatient costs for the DRG group. Results The median of inpatient costs in the clinical pathway group was 9239.41 yuan, was lower than that of control group which was 12358.06 yuan, and the difference was statistical difference (P<0.001). Cost composition analysis found that the costs of treatment, examination, medicine, surgery and the others in the clinical pathway group were much lower than that of the control group, while the cost of materials was relatively high. Among the 14 DRG group study, there were 6 DRG groups which the inpatient costs of the clinical path group was obviously lower than the control group. Conclusion The implementation of clinical pathway management may reduce the inpatient costs and change the makeup of costs. Therefore, combining with DRG, we actively promote the refined management of clinical pathway, which may effectively control the costs of diseases and the unreasonable growth of medical expenses.
临床诊疗

骨科手术患者住院费用影响因素分析

:117-122
 
目的 探讨骨科手术患者住院费用的影响因素,为疾病负担分析提供线索,为合理有效控制骨科手术患者住院费用增长提供参考依据。方法 提取某院2013年、2018年两年全部骨科手术患者住院病案首页信息,对其进行统计分析,利用单因素分析、多元线性回归分析住院总费用的影响因素。结果 住院年份、性别、年龄、住院天数、出院科室、是否患有慢性内科疾病、切口愈合类型、麻醉方式、是否转科、病例分型、入院途径、手术是否择期和手术级别等是影响住院总费用的因素。合并慢性病患者,住院费用多于未合并者(P<0.000 1),病例分型为疑难危重患者住院费用大于一般患者(P<0.000 1),入院途径为急诊患者住院费用大于门诊患者(P<0.000 1),需转科患者住院费用大于未转科患者(P<0.000 1),三、四级手术患者住院费用高于一、二级手术患者(P<0.000 1)。结论 加强慢性病的防治,提高对疑难、急危重症患者的诊治水平,是缩短平均住院日、降低骨科手术患者住院费的一个重要途径。
论著

乳腺恶性肿瘤患者诊断及治疗方法动态变化

Dynamic changes of diagnosis and treatment in patients with breast cancer

:18-21
 
目的 分析乳腺恶性肿瘤患者的诊断和治疗方法的动态变化,了解该疾病的患者诊治相关行为方式的变化。方法 抽取我院1999年—2014年收治的所有乳腺恶性肿瘤患者,比较不同初诊时间和初诊年龄分组间,患病部位、肿瘤大小、手术方式、治疗方式的差异。结果 比较1999年—2004年组、2005—2009年组,近年诊断的肿瘤最大直径有所下降,经过卡方比较,构成比有差异(χ2=14.2,P=0.007)。近年诊断的患者更愿意选择积极的改良根治术作为手术治疗方式(χ2=38.8,P<0.001)。就不同年龄而言,年轻的患者选择改良根治术和化疗的比例也较年老的患者高,而年龄大的患者则选择姑息治疗的比例较高(χ2=154.9,P<0.001)和(χ2=129.8,P<0.001)。结论 乳腺恶性肿瘤的认知的加强,诊治技术的提高,乳腺恶性肿瘤能够更早的被发现诊断,治疗方式的选择也更加积极。
Objective To analyze the dynamic changes of breast cancer diagnosis and treatment. and to understand the changes of related behaviors of the patients. Methods From 1999 to 2014, breast cancer patients were chosen, the differences of tumor size, operation and treatment were not compared. Results The results were compared within different groups of diagnosis years, such as 1999-2004,2005-2009, and 2010-2015. The maximum diameter of the tumor diagnosed in recent years was decreased, χ2=14.2,P= 0.007. At the same time, patients that were diagnosed in recent years were more likely to choose radical surgery as surgical treatment, χ2=38.8,P<0.001. Comparing within groups of different ages, more patients chose radical surgery and chemotherapy in younger patients than older ones, we found that the older patients chose a higher proportion of palliative care, χ2=154.9,P<0.001 and χ2=129.8,P<0.001. Conclusion Understan-ding of breast cancer malignancies was enhanced. Breast cancer may be diagnosed earlier and the choice of treatment is more positive with the development of technology.
出版者信息








《广州医药》公众号